Side-by-side comparison of AI visibility scores, market position, and capabilities
Arable monitors crop microclimate, soil moisture, and plant health in real time using field-deployed sensors, helping growers optimize irrigation and reduce risk.
Arable is a precision agriculture platform built around a proprietary multi-sensor device — the Arable Mark — that measures crop microclimate, solar radiation, plant canopy temperature, rainfall, soil moisture, and evapotranspiration directly in the field. Unlike weather stations that measure ambient conditions at a distance from crops, the Arable Mark is deployed within the crop canopy to capture the thermal and moisture environment that plants actually experience. This microclimate data feeds agronomic models that estimate crop water stress, predict irrigation demand, and forecast pest and disease pressure with field-level precision.
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.